|Issuer:||FLEXION THERAPEUTICS INC (FLXN)|
|Original Submission Date:|
C/O FLEXION THERAPEUTICS, INC.
10 MALL ROAD, SUITE 301 BURLINGTON, MA 01803
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|f1||the weighted average purchase price for the transaction reported was $11.99, and the range of prices were between $11.9877 and $11.9879. upon request by the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.|